SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
RALEIGH, N.C., Aug. 21, 2017 -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization, today announced that Chief Financial Officer Greg Rush is scheduled to present at two upcoming investor conferences.
Mr. Rush is scheduled to present during the 2017 Wells Fargo Healthcare Conference in Boston, MA, on Wednesday, September 6, 2017, at 8:30 a.m. EDT.
Mr. Rush is scheduled to present during the 2017 Robert W. Baird Global Healthcare Conference in New York, NY, on Thursday, September 7, 2017, at 2:00 p.m. EDT.
Links to INC/inVentiv’s live presentation and archived audio replay, as well as the presentation materials, will be available via the Company’s Investor Relations website at investor.incresearch.com.
About INC Research/inVentiv Health
INC Research/inVentiv Health (Nasdaq:INCR) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to address new market realities where clinical and commercial share expertise, data and insights to accelerate biopharmaceutical performance. With more than 22,000 employees and the ability to support customers in more than 110 countries, our global scale and deep therapeutic alignment enables INC Research/inVentiv Health to help customers successfully navigate an increasingly complex environment. For more information on our Raleigh, N.C.-based company, visit incresearch.com or inventivhealth.com.
Investor Relations Contact: Ronnie Speight Vice President, Investor Relations +1 919 745 2745 [email protected] Press/Media Contact: Danielle DeForge Senior Director, External Communications +1 781 425 2624 [email protected]
